Search results
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology via Yahoo Finance· 2 days agoZai Lab has announced that its New Drug Application (NDA) for Augtyro (repotrectinib) has been...
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 5 days agoCatalyst Pharmaceuticals' new Chief Executive, Richard Daly, is no stranger to working at big...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 2 days agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
2seventy bio Inc (TSVT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and ...
GuruFocus.com via Yahoo Finance· 6 days agoRevenue: Acme U.S. revenues reported by Bristol-Myers Squibb for $52 million. Net Income: Share of collaboration loss of $1.2 million related to collaboration with BMS. Cost Savings: Expected ...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 days agoFor Immediate Release Chicago, IL – May 13, 2024 – Zacks Equity Research shares Veeva Systems VEEV...
Biotech Slumps Despite 'Pristine' Results For Bristol-Rivaling Heart Drug
Investor's Business Daily· 2 days agoThe company tested its drug, aficamten, in patients with obstructive hypertrophic cardiomyopathy, or...
Getting In on This “Macro-Trend”
InvestorPlace via Yahoo Finance· 7 days agoHello, Reader. Wall Street has sold investors on the idea that they should start with “micro” analysis. That’s the idea that they should make investment decisions by comparing things like price ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1506 ET...
Are Diabetes Drugs Set to Move OA Management Forward?
Medscape· 1 day agoAre Diabetes Drugs Set to Move Osteoarthritis Management Forward? VIENNA — With the glucagon-like...
FogPharma, Artbio join forces to design a different radiopharma drug
BioPharma Dive via Yahoo Finance· 1 day agoThe biotechs aim to marry FogPharma’s polypeptide science with Artbio’s lead-based...